More Progress on Amniotic Injections Advocacy Efforts | News | APMA
More Progress on Amniotic Injections Advocacy Efforts

April 4, 2022

Update! written on green paper in clothespin

Since the last APMA update on this subject, all seven Part B Medicare Administrative Contractors (MACs) have removed the guidance that they would be denying claims for amniotic injections for musculoskeletal conditions effective March 16, and recouping payment for claims going back to December 6, 2019. APMA is collaborating with others to determine exactly what the removal of this guidance means for its members.

APMA encourages members who perform this service and submit for payment of this service to third-party payers to follow that payer’s current guidelines regarding provision of this service. Be sure to follow APMA’s Weekly Focus and visit and for updates.

Leave Your Thoughts

Please sign in to leave a comment

Related Resources

APMA Supports Accurate Coding Terminology at CPT® Meeting

Learn More

APMA Submits Recommendations to CMS on Medicare Advantage Program on Supplemental Benefits and Prior Authorization

Learn More

Subscribe, browse, or contribute to JAPMA